Wednesday, October 20, 2021

NEUROPHARMACOLOGIST GRAHAM BIRRELL JOINS GEORGE CLINICAL TO LEAD APAC OPERATIONS

KUALA LUMPUR, Oct 20 (Bernama) -- George Clinical, a global scientifically-backed clinical research organisation, has announced the designation of Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region, as Head, Project Operations, APAC.

He will also join the scientific leadership of George Clinical with a neurology focus, according to a statement.

In his new role with George Clinical, Birrell will be based in the Asia Pacific region overseeing the extensive project teams the firm has throughout Australia, New Zealand, China, Taiwan, Malaysia, the Philippines, Singapore and South Korea.

“Graham is a natural lead for our diverse APAC operations given his multifaceted background in operations, management and developing business with strategic clients,” said Chief Medical Officer Maria Ali. 

“With the burgeoning interest running trials across APAC, Graham will be critical in helping sponsors leverage our best-in-class CRO networks and expertise.”

Meanwhile, Birrell said: “I’m excited to serve George Clinical clients and teams across this diverse region and partner with our business teams around the globe as we continue setting the standard in APAC clinical research.”

Birrell’s more than 30 years of biopharmaceutical industry experience includes drug discovery and development including positions with GSK, Pfizer and Servier, clinical operations, project management, regulatory consulting, and business development.

Formerly serving as VP, Clinical Development, Travecta Therapeutics, he has also held senior management roles in the UK and Singapore with CROs such as Parexel, ICON, IQVIA and most recently Syneos Health.

Over the last two decades, he has worked on more than 50 clinical development programmes, including the management of 14 Phase II-III global programmes for central nervous system (CNS), oncology, rheumatology, diabetes, respiratory, ophthalmology and vaccine therapies which were successfully launched into the market.  

More details at https://www.georgeclinical.com.

-- BERNAMA

No comments:

Post a Comment